
For real world
clinical practice
Cardiology

The DASH trial: Diet change significantly reduces blood pressure
This is a Module from the Course

The DIG Trial: Digoxin reduces hospitalization in patients with systolic heart failure
This is a Module from the Course

The ENHANCE trial: Simvastatin and ezetimibe in familial hypercholesterolemia
This is a Module from the Course

The FAME 3 Trial: Fractional Flow Reserve-Guided PCI Compared with Coronary Bypass Surgery
This is a Module from the Course

The FAME 3 Trial: Fractional Flow Reserve-Guided PCI Compared with Coronary Bypass Surgery
This is a Module from the Course

The HMPS I trial: Adverse events in patients and negligence
This is a Module from the Course

The HOPE Trial: Ramipril reduces cardiovascular events in high-risk patients with normal ejection fractions
This is a Module from the Course

The HOT trial: Diastolic blood pressure targets in hypertension
This is a Module from the Course

The JUPITER: Rosuvastatin reduces the risk of major cardiovascular events in healthy patients
This is a Module from the Course

The LRC-CPPT 1: Cholestyramine and coronary heart disease
This is a Module from the Course

The MERIT-HF Trial: Metoprolol reduces mortality in patients with symptomatic heart failure
This is a Module from the Course

The MIRACL Trial: Atorvastatin reduces recurrent ischemia after acute coronary syndrome
This is a Module from the Course

The RALES Trial: Spironolactone reduces mortality in heart failure patients
This is a Module from the Course

The REMATCH Trial: Left ventricular assist devices reduce mortality in heart failure
This is a Module from the Course

The SAVE Trial: Captopril reduces mortality after acute myocardial infarction
This is a Module from the Course

The SOLVD Trial: Enalapril reduces mortality in heart failure with reduced ejection fraction
This is a Module from the Course

The UKPDS: Reducing diabetes-related morbidity and mortality
This is a Module from the Course

The Val-HeFT Trial: Valsartan reduces morbidity in chronic heart failure
This is a Module from the Course

The V-HeFT I: Hydralazine and isosorbide dinitrate reduce mortality in heart failure
This is a Module from the Course

The V-HeFT II Trial: Enalapril reduces mortality in heart failure when compared to hydralazine and isosorbide
This is a Module from the Course